The use of rituximab as an adjuvant in the treatment of oral pemphigus vulgaris.

Fortuna, Giulio; Calabria, Elena; Ruoppo, Elvira; Adamo, Daniela; Aria, Massimo; Amato, Massimo; Mignogna, Michele D

Fortuna, Giulio; Calabria, Elena; Ruoppo, Elvira; Adamo, Daniela; Aria, Massimo; Amato, Massimo; Mignogna, Michele D.

Afiliação

Fortuna G; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University of Naples, Naples, Italy.
Calabria E; D.eb.RA. Mexico Foundation, Guadalupe N.L., Monterrey, Mexico.
Ruoppo E; Federico Navarro Institute - School of Orgonomy "Piero Borrelli", Naples, Italy.
Adamo D; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University of Naples, Naples, Italy.
Aria M; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University of Naples, Naples, Italy.
Amato M; Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University of Naples, Naples, Italy.
Mignogna MD; Department of Economics and Statistics, Federico II University of Naples, Naples, Italy.

J Oral Pathol Med ; 49(1): 91-95, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31420993

Assuntos

Pênfigo; Rituximab/uso terapêutico; Desmogleína 3; Humanos; Imunossupressores; Pênfigo/tratamento farmacológico; Estudos Retrospectivos

Palavras-chave

OPV; desmoglein; disease severity; oral pemphigus vulgaris; remission; rituximab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pênfigo / Rituximab Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Oral Pathol Med Assunto da revista: ODONTOLOGIA / PATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google